` MROPF (Microport Cardioflow Medtech Corp) vs S&P 500 Comparison - Alpha Spread

MROPF
vs
S&P 500

Over the past 12 months, MROPF has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +19% growth.

Stocks Performance
MROPF vs S&P 500

Loading
MROPF
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
MROPF vs S&P 500

Performance Gap Between MROPF and GSPC
HIDDEN
Show

Performance By Year
MROPF vs S&P 500

Loading
MROPF
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Microport Cardioflow Medtech Corp vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Microport Cardioflow Medtech Corp
Glance View

Market Cap
1.6B USD
Industry
Health Care

MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-02-04. The firm is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The firm's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The firm mainly conducts business within the domestic market.

MROPF Intrinsic Value
HIDDEN
Show
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett